Pericarditis and Myocarditis: The Heart Inflammation Conditions That Can Follow Infection
Most people recover from a viral infection within a week or two and give it little further thought. Yet for some, the immune system’s response to that infection does not stop at the throat or lungs. Instead, it extends to the heart itself, triggering inflammation that can cause significant chest pain, breathlessness, and in serious cases, lasting cardiac damage.
Pericarditis and myocarditis are two distinct but related heart inflammation conditions. Both can follow common infections, and both deserve far greater public awareness. Understanding the difference between them, recognising their symptoms, and knowing when to seek help can genuinely save lives.
Understanding the Heart’s Layers
The heart has three main layers, each of which can become inflamed under different circumstances. The outermost layer is the pericardium — a protective double-walled sac that surrounds and cushions the heart. The middle and thickest layer is the myocardium, which is the muscular wall responsible for pumping blood.
Why Inflammation Matters
Inflammation is the body’s natural defence response to infection, injury, or immune activation. When this response targets the heart, it disrupts the organ’s normal structure and function. Unlike inflammation in the skin or a joint, cardiac inflammation can interfere directly with the heart’s ability to beat effectively.
Both pericarditis and myocarditis can occur separately or simultaneously. When both layers inflame together, doctors call the condition myopericarditis. Recognising which structure is predominantly affected guides treatment decisions and prognosis.
What Is Pericarditis?
Pericarditis is inflammation of the pericardium — the thin, fluid-filled sac surrounding the heart. The pericardium normally contains a small amount of lubricating fluid that allows the heart to move freely within the chest. When inflamed, the pericardial layers become irritated, rough, and swollen.
How Pericarditis Develops
Viruses are the most common trigger for pericarditis in high-income countries, accounting for up to 90% of cases in some studies. Enteroviruses, including coxsackievirus B, adenoviruses, and influenza viruses are frequent culprits. More recently, SARS-CoV-2 (the virus causing COVID-19) has emerged as an important cause of both pericarditis and myocarditis.
In many cases, doctors cannot identify a specific viral cause, and the condition is labelled idiopathic — meaning no clear cause is found. Despite the absence of a confirmed pathogen, the underlying mechanism is almost certainly viral or immune-mediated.
Other Causes of Pericarditis
Beyond viral infection, pericarditis can result from bacterial infections, including tuberculosis, which remains an important cause in lower-income settings. Autoimmune diseases such as lupus (systemic lupus erythematosus), rheumatoid arthritis, and inflammatory bowel disease can trigger pericarditis through immune dysregulation. Additionally, pericarditis may develop following heart surgery, heart attack, chest trauma, or certain medications.
What Is Myocarditis?
Myocarditis is inflammation of the myocardium — the heart muscle itself. Unlike pericarditis, which primarily causes pain from irritated surfaces, myocarditis directly impairs the heart muscle’s ability to contract and pump blood. This makes myocarditis potentially more dangerous, particularly in young, otherwise healthy individuals.
Viral Triggers of Myocarditis
Viruses are also the leading cause of myocarditis. Enteroviruses, particularly coxsackievirus B3, have long been associated with myocarditis. Adenoviruses, parvovirus B19, human herpesvirus 6, and influenza viruses are among many other viral triggers identified in clinical studies.
COVID-19 has attracted significant attention as a cause of myocarditis, both from the virus itself and, rarely, following mRNA vaccination. The risk from COVID-19 infection substantially exceeds the rare vaccine-associated risk, a point supported by multiple international health authorities.
Non-Viral Causes of Myocarditis
Bacterial infections, including Staphylococcus aureus, Borrelia burgdorferi (causing Lyme disease), and Trypanosoma cruzi (causing Chagas disease in Central and South America) can all cause myocarditis. Autoimmune conditions including sarcoidosis, giant cell myocarditis, and eosinophilic myocarditis represent important non-infectious causes.
Certain medications and toxins — including some chemotherapy agents, cocaine, and excessive alcohol — can trigger toxic myocarditis. Identifying the underlying cause is critical because it influences both treatment and prognosis.
Who Is Most at Risk?
Both pericarditis and myocarditis can affect people of any age, but certain groups carry a higher risk.
Age and Sex Differences
Pericarditis affects males more commonly than females, with peak incidence in adults aged 20–50 years. Myocarditis also predominantly affects younger individuals, with a particular predilection for males between 15 and 45 years of age. The reasons for this sex difference are not fully understood but likely involve hormonal and immune system variations.
Conditions That Increase Risk
People with autoimmune diseases carry a significantly elevated risk of developing inflammatory cardiac conditions. Those who are immunocompromised — whether from HIV infection, organ transplantation, or immunosuppressive therapy — face heightened vulnerability to viral and bacterial triggers.
Athletes who exercise intensely while acutely unwell with viral illness face a particularly serious risk of myocarditis. Continued strenuous exercise during active cardiac inflammation can precipitate dangerous arrhythmias and sudden cardiac arrest. This is why sports medical guidelines universally advise resting during acute viral illness.
Symptoms of Pericarditis
Pericarditis produces a distinctive set of symptoms that, once recognised, are relatively characteristic.
Chest Pain in Pericarditis
Sharp, stabbing chest pain is the hallmark symptom of pericarditis. The pain typically worsens when lying flat and improves when sitting forward — a feature that helps distinguish it from other causes of chest pain such as heart attack. Deep breathing, coughing, and swallowing can also intensify the discomfort.
The pain often radiates to the left shoulder or neck, reflecting the pericardium’s anatomical proximity to the diaphragm and nearby nerves. Patients frequently describe the pain as pleuritic — meaning it varies in intensity with breathing.
Other Pericarditis Symptoms
Low-grade fever commonly accompanies pericarditis, reflecting the underlying inflammatory process. Many patients report fatigue, general malaise, and muscle aches consistent with a viral prodrome — the flu-like symptoms that often precede cardiac inflammation by days to weeks.
A pericardial friction rub — a scratching or creaking sound heard through a stethoscope — represents the hallmark clinical sign. This distinctive sound arises from the inflamed pericardial layers rubbing against each other with each heartbeat. Its presence is highly diagnostic of pericarditis on physical examination.
Cardiac Tamponade: A Dangerous Complication
In some cases, excessive fluid accumulates between the pericardial layers — a condition called pericardial effusion. When the fluid accumulates rapidly or in large volumes, it compresses the heart and impairs its ability to fill with blood. This life-threatening emergency, called cardiac tamponade, causes breathlessness, low blood pressure, muffled heart sounds, and neck vein distension. It requires emergency drainage of the fluid.
Symptoms of Myocarditis
Myocarditis presents more variably than pericarditis, and its symptoms range from mild to immediately life-threatening.
Mild to Moderate Presentations
Many people with mild myocarditis experience only subtle symptoms, including fatigue, chest discomfort, breathlessness on exertion, and palpitations. These symptoms often develop one to four weeks after a viral infection, at a stage when the person may feel generally recovered. This temporal gap frequently leads patients to overlook the connection between their prior illness and new cardiac symptoms.
Fever and generalised aches may persist or recur during the acute myocarditis phase. Some patients notice their heart racing or skipping beats, reflecting inflammation-induced electrical instability.
Severe Myocarditis
Severe myocarditis causes rapidly progressive heart failure, with profound breathlessness at rest, fluid accumulation in the lungs, and severely reduced cardiac output. Life-threatening arrhythmias — including ventricular tachycardia and ventricular fibrillation — can develop without warning. This fulminant form of myocarditis can be fatal within hours to days if not immediately recognised and treated.
Myocarditis accounts for a meaningful proportion of sudden cardiac deaths in young athletes and military recruits. Recognising the warning signs of unexplained breathlessness or palpitations following viral illness is therefore critically important in this population.
Chest Pain in Myocarditis
Chest pain in myocarditis is often dull and persistent rather than the sharp, positional pain of pericarditis. The discomfort reflects direct inflammation within the heart muscle and can closely mimic the chest pain of a heart attack. Elevated cardiac enzymes in blood tests help distinguish myocarditis from acute coronary syndrome in the clinical setting.
How Doctors Diagnose These Conditions
Diagnosing pericarditis and myocarditis requires integrating clinical findings, laboratory tests, electrocardiography, and cardiac imaging.
Electrocardiography (ECG)
An ECG records the electrical activity of the heart and provides important diagnostic information in both conditions. Pericarditis produces a characteristic pattern of diffuse ST elevation — changes affecting nearly all leads — along with PR segment depression. These widespread changes, in contrast to the localised changes seen in heart attack, are an important distinguishing feature.
Myocarditis produces more variable ECG changes, including ST elevation, T wave abnormalities, and arrhythmias. Non-specific ECG changes in the context of recent viral illness and cardiac symptoms should prompt further cardiac investigation.
Blood Tests
Elevated cardiac biomarkers — troponin T or troponin I — indicate cardiac muscle cell damage and are characteristic of myocarditis. Inflammatory markers including C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) are elevated in both conditions. A raised white cell count reflects active immune response.
Viral serology, autoimmune antibody panels, and thyroid function tests help identify specific underlying causes and guide management.
Echocardiography
Echocardiography provides vital information about cardiac structure and function. In pericarditis, it detects pericardial effusion and assesses whether cardiac tamponade is developing. In myocarditis, it reveals reduced heart muscle function, regional wall motion abnormalities, and dilation of the cardiac chambers in severe cases.
Echocardiography is non-invasive, widely available, and provides rapid bedside information in acutely unwell patients.
Cardiac MRI
Cardiac magnetic resonance imaging (MRI) is the gold standard non-invasive test for diagnosing myocarditis. Using specific imaging sequences including T2-weighted imaging and late gadolinium enhancement, cardiac MRI detects the characteristic pattern of myocardial inflammation and oedema. It provides precise information about the extent and distribution of inflammation within the heart muscle.
Cardiac MRI also detects pericardial inflammation and effusion with high sensitivity. Many specialist centres now include cardiac MRI in the routine evaluation of suspected myocarditis, particularly in young patients and athletes.
Endomyocardial Biopsy
Endomyocardial biopsy — sampling a small piece of heart muscle through a catheter — represents the definitive diagnostic test for myocarditis. However, clinicians reserve this invasive procedure for cases of severe or unexplained myocarditis where histological confirmation would change management. The Dallas criteria provide the histological definition of myocarditis on biopsy specimens.
Treatment of Pericarditis
Most cases of viral or idiopathic pericarditis respond well to medical treatment, with the majority of patients achieving full recovery.
Anti-Inflammatory Medications
Non-steroidal anti-inflammatory drugs (NSAIDs) — such as ibuprofen or aspirin — form the cornerstone of pericarditis treatment. They reduce inflammation, relieve chest pain, and speed recovery. Doctors prescribe them in full therapeutic doses, typically for one to four weeks, with gradual tapering to prevent symptom recurrence.
Colchicine, an anti-inflammatory medication originally used for gout, significantly improves outcomes when added to NSAID therapy. The landmark COPE and ICAP trials demonstrated that colchicine reduces the risk of pericarditis recurrence by approximately 50%. Current guidelines recommend colchicine for all patients with a first episode of acute pericarditis.
Corticosteroids and Recurrent Pericarditis
Corticosteroids such as prednisolone are reserved for patients who fail to respond to NSAIDs and colchicine, or for those with autoimmune or tuberculous pericarditis. However, high-dose corticosteroids increase the risk of pericarditis recurrence, so their use requires careful specialist guidance.
Recurrent pericarditis — defined as a relapse after a symptom-free interval of at least four to six weeks — affects approximately 15–30% of patients. Interleukin-1 inhibitors such as anakinra and rilonacept represent newer biological therapies for refractory recurrent pericarditis, showing significant efficacy in clinical trials.
Draining Pericardial Effusion
When a significant pericardial effusion develops, or when cardiac tamponade threatens, doctors perform pericardiocentesis — a procedure to drain the accumulated fluid using a needle guided by echocardiography or fluoroscopy. This procedure rapidly relieves cardiac compression and can be life-saving in urgent situations.
Treatment of Myocarditis
Treating myocarditis requires a tailored approach based on disease severity, causative agent, and the degree of cardiac dysfunction.
Rest and Activity Restriction
Physical rest is a cornerstone of myocarditis management. Clinicians strongly advise against exercise during active myocarditis, as exertion dramatically increases the risk of fatal arrhythmias. Current guidelines recommend avoiding competitive sport and high-intensity exercise for a minimum of three to six months following acute myocarditis.
Return to exercise requires careful reassessment including repeat cardiac imaging, ECG, and sometimes exercise stress testing. Premature return to vigorous activity before the heart has fully recovered carries serious risks.
Heart Failure Medications
Patients with myocarditis-related heart failure receive standard heart failure medications to reduce the heart’s workload and support recovery. ACE inhibitors or angiotensin receptor blockers reduce cardiac afterload. Beta-blockers lower heart rate and protect against arrhythmias. Diuretics relieve fluid overload and breathlessness.
Mineralocorticoid receptor antagonists such as spironolactone provide additional benefit in moderate to severe heart failure. These medications collectively support myocardial recovery while the inflammation resolves.
Managing Arrhythmias
Cardiac monitoring is essential during acute myocarditis because dangerous arrhythmias can develop rapidly. Continuous ECG monitoring in hospital allows early detection and treatment of ventricular arrhythmias. Antiarrhythmic medications help suppress electrical instability during the acute phase.
In severe cases with refractory arrhythmias or acute haemodynamic collapse, advanced support including intra-aortic balloon pumps, ventricular assist devices, or extracorporeal membrane oxygenation (ECMO) may bridge patients to recovery or heart transplantation.
Immunosuppression in Selected Cases
Immunosuppressive therapy with corticosteroids and azathioprine benefits patients with specific histologically confirmed subtypes of myocarditis, including giant cell myocarditis and autoimmune myocarditis. Viral myocarditis does not routinely benefit from immunosuppression during the acute phase. Careful histological classification guides these treatment decisions.
Recovery and Long-Term Outlook
The prognosis for both pericarditis and myocarditis depends on the underlying cause, severity, and timeliness of treatment.
Recovery From Pericarditis
Most patients with viral or idiopathic pericarditis recover fully within three to six weeks with appropriate anti-inflammatory treatment. Recurrence remains the most common complication, affecting a significant minority of patients despite optimal initial therapy. Constrictive pericarditis — a serious complication where the pericardium becomes thickened and scarred, constricting the heart — develops rarely but may eventually require surgical removal of the pericardium.
Recovery From Myocarditis
The majority of patients with mild to moderate myocarditis recover complete cardiac function within weeks to months. However, a proportion develop dilated cardiomyopathy — a condition where the heart muscle becomes weakened and enlarged — leading to chronic heart failure that persists beyond the acute episode.
Fulminant myocarditis carries a paradoxically better long-term prognosis than subacute forms if patients survive the acute phase with intensive support. Giant cell myocarditis carries a more guarded prognosis and often requires aggressive immunosuppression or heart transplantation.
Importance of Follow-Up Care
Long-term cardiac follow-up is essential for all patients recovering from myocarditis. Repeat echocardiography and cardiac MRI assess the completeness of myocardial recovery and detect any residual scarring. Patients with persistent left ventricular dysfunction require ongoing heart failure management under specialist supervision.
Frequently Asked Questions
What is the difference between pericarditis and myocarditis?
Pericarditis is inflammation of the pericardium — the outer protective sac surrounding the heart — causing chest pain that varies with position and breathing. Myocarditis is inflammation of the myocardium — the heart muscle itself — which directly impairs the heart’s pumping function. Both conditions can follow viral infections, but myocarditis generally carries greater potential for serious cardiac complications.
Can COVID-19 cause pericarditis or myocarditis?
Yes, COVID-19 can cause both pericarditis and myocarditis, either during active infection or as part of a post-COVID inflammatory syndrome. Multiple studies have documented cardiac inflammation following COVID-19, particularly in hospitalised patients with severe disease. Vaccine-associated myocarditis, predominantly in young males after mRNA vaccination, occurs rarely and is generally mild and self-limiting, representing a far smaller risk than myocarditis from COVID-19 infection itself.
How long does recovery from pericarditis take?
Most people recover fully from a first episode of acute viral pericarditis within three to six weeks with appropriate anti-inflammatory treatment. Recurrent pericarditis can prolong the recovery process considerably, sometimes requiring long-term medication. Patients should avoid vigorous exercise and heavy lifting until symptoms fully resolve and their doctor confirms clearance.
Is myocarditis dangerous for athletes?
Myocarditis poses a serious danger for athletes because physical exertion during active cardiac inflammation dramatically increases the risk of sudden cardiac death from ventricular arrhythmias. Sports cardiology guidelines universally recommend complete abstinence from competitive sport during active myocarditis and a structured return-to-sport protocol thereafter. Young athletes experiencing unexplained breathlessness, palpitations, or chest pain after a viral illness should seek immediate cardiac evaluation before resuming exercise.
Can pericarditis or myocarditis come back?
Pericarditis recurs in approximately 15–30% of patients after a first episode. Recurrent pericarditis can become a chronic, debilitating condition requiring prolonged anti-inflammatory therapy. Myocarditis recurrence is less common but possible, particularly in patients with autoimmune conditions or repeated viral exposures. Both conditions benefit from specialist follow-up to detect and manage recurrence promptly.
What foods or activities should someone avoid during recovery?
During recovery from either condition, patients should avoid strenuous physical exercise, competitive sports, and heavy physical labour until medically cleared. Alcohol should be minimised or avoided entirely during the acute phase, as it can worsen cardiac inflammation. A heart-healthy diet rich in vegetables, fruits, whole grains, and lean protein, combined with adequate rest, supports immune function and cardiac recovery.
Conclusion
Pericarditis and myocarditis remind us that the heart does not exist in isolation from the rest of the body. A viral infection that seems routine can, in certain individuals, trigger an immune response that reaches the heart itself. Recognising the warning signs — particularly chest pain, breathlessness, and palpitations following recent illness — and acting swiftly can prevent serious, lasting harm.
Advances in cardiac imaging, particularly cardiac MRI, have transformed the ability to diagnose these conditions accurately and early. Equally important are awareness campaigns that help patients, coaches, parents, and healthcare providers understand when cardiac inflammation might be developing. Your heart is worth protecting — and knowing the early signs of inflammation is one of the most powerful tools available.
References
- Long QT syndrome is an inherited cardiac arrhythmia disorder caused by genetic mutations affecting ion channels that control heart electrical activity.Â
- The heart is a muscle that contracts to work as a pump. When it contracts it pushes blood – containing oxygen and nutrients – to all the tissues of our body.
- At the most visible level, human experience is defined by daily interactions and sensory input.Â
- World Heart Day, is celebrated on September 29 to spread awareness around cardiovascular diseases and reduce the global disease burden
Disclaimer:
This article is intended for general informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for personalised diagnosis, treatment, or health guidance.
Observer Voice is the one stop site for National, International news, Sports, Editor’s Choice, Art/culture contents, Quotes and much more. We also cover historical contents. Historical contents includes World History, Indian History, and what happened today. The website also covers Entertainment across the India and World.
